Re Rights Issue

Costain Group PLC 14 September 2007 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES, CANADA, FRANCE, JAPAN, MALAYSIA, NEW ZEALAND, SOUTH AFRICA OR SWITZERLAND OR IN OR INTO ANY JURISDICTION WHERE TO DO SO WOULD BREACH ANY APPLICABLE LAW. Costain Group plc ('Costain') PUBLICATION OF PROSPECTUs Further to the announcement made earlier today, Costain announces that the prospectus (the 'Prospectus') in connection with the three for four rights issue (the 'Rights Issue') of new ordinary shares (the 'New Ordinary Shares') to raise approximately £60 million (net of expenses) at an issue price of 24 pence per New Ordinary Share is being posted today. Costain shareholders (subject to certain exceptions) will be mailed a Prospectus (which includes notice of an extraordinary general meeting (the 'Extraordinary General Meeting') to be held at 10:30am on 2 October 2007 in connection with the Rights Issue) and a form of proxy (the 'Form of Proxy') in respect of the Extraordinary General Meeting. Copies of the Prospectus and Form of Proxy will be available in due course from the Company's website at www.costain.com, and will be available for inspection during normal business hours on Monday to Friday each week (public holidays excepted) from and including the date of publication of the Prospectus until 26 October 2007, at the registered office of Costain at Costain House, Nicholsons Walk, Maidenhead, Berkshire SL6 1LN. Copies of the Prospectus will be made available free of charge upon request. In addition, the Prospectus and Form of Proxy will shortly be available for inspection at the UK Listing Authority's Document Viewing Facility at the Financial Services Authority, 25 North Colonnade, Canary Wharf, London, E14 5HS. 14 September 2007 Contacts: Costain Group PLC Tel: 020 7705 8444 Andrew Wyllie, Group Chief Executive Tony Bickerstaff, Group Finance Director Hawkpoint Partners Limited (Financial adviser and Sponsor) Tel: 020 7665 4500 Christopher Kemball Chris Robinson Arbuthnot Securities Limited (Joint broker to Costain) Tel: 020 7012 2000 James Steel Richard Dunn Dresdner Kleinwort Limited (Joint broker to Costain) Tel: 020 7623 8000 Charles Batten Michael Covington College Hill (PR advisers) Tel: 020 7457 2020 Mark Garraway Matthew Gregorowski Hawkpoint Partners Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting as financial adviser and sponsor to Costain and is acting for no one else in connection with the Rights Issue and will not be responsible to anyone other than Costain for providing the protections afforded to clients of Hawkpoint Partners Limited, nor for providing advice in connection to the Rights Issue or any other matter referred to herein. Arbuthnot Securities Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively for Costain and for no one else in connection with matters described in this announcement and is not advising any other person or treating any other person as its client in relation to matters described in this announcement and will not be responsible to anyone other than Costain for providing the protections afforded to clients of Arbuthnot Securities Limited, or for giving advice to any other person in relation to the contents of this announcement or any other matter referred to in this announcement. Dresdner Kleinwort Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively for Costain and for no one else in connection with matters described in this announcement and is not advising any other person or treating any other person as its client in relation to matters described in this announcement and will not be responsible to anyone other than Costain for providing the protections afforded to clients of Dresdner Kleinwort Limited, or for giving advice to any other person in relation to the contents of this announcement or any other matter referred to in this announcement. This announcement does not constitute an offer to sell or the solicitation of an offer to acquire or subscribe for New Ordinary Shares. The offer to acquire New Ordinary Shares pursuant to the proposed Rights Issue will be made solely on the basis of the information contained in the Prospectus. This announcement is not an offer of securities for sale in, into or from the United States, Canada, France, Japan, Malaysia, New Zealand, South Africa or Switzerland. The New Ordinary Shares have not been and will not be registered under the US Securities Act of 1933 (as amended) or under any relevant securities laws of any state or other jurisdiction of the United States, and will not qualify for distribution under any of the relevant securities laws of Canada, France, Japan, Malaysia, New Zealand, South Africa or Switzerland. Accordingly, the New Ordinary Shares may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within the United States (absent registration or an applicable exemption from registration) or within Canada, France, Japan, Malaysia, New Zealand, South Africa or Switzerland. This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings